F Benazzi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAntipsychotic Agents/administration & dosageAntipsychotic Agents/adverse effectsClonazepam/administration & dosageClonazepam/adverse effectsComorbidityConstipation/chemically inducedDelusions/diagnosisDelusions/drug therapyDrug Therapy, CombinationFemaleGABA Modulators/administration & dosageGABA Modulators/adverse effectsHaloperidol/administration & dosageHaloperidol/adverse effectsHumansObsessive-Compulsive Disorder/diagnosisObsessive-Compulsive Disorder/drug therapyPanic Disorder/diagnosisPanic Disorder/drug therapySerotonin Uptake Inhibitors/administration & dosageSerotonin Uptake Inhibitors/adverse effectsSertraline/administration & dosageSertraline/adverse effectsUrinary Retention/chemically inducedUrinary Retention/diagnosis
Substances： See more » Antipsychotic AgentsGABA ModulatorsSerotonin Uptake InhibitorsClonazepamHaloperidolSertraline
Year: 1998 PMID： 9868574
Source DB: PubMed Journal: Can J Psychiatry ISSN： 0706-7437 Impact factor: 4.356